SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-047349
Filing Date
2021-09-08
Accepted
2021-09-08 16:00:31
Documents
4
Period of Report
2021-09-08

Document Format Files

Seq Description Document Type Size
1 6-K tlc-6k_20210908.htm 6-K 19730
2 EX-99.1 tlc-ex991_6.htm EX-99.1 9856
3 GRAPHIC g4u1vf2cm1wv000002.jpg GRAPHIC 89025
4 GRAPHIC g4u1vf2cm1wv000001.jpg GRAPHIC 41354
  Complete submission text file 0001564590-21-047349.txt   210181
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Filer) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38746 | Film No.: 211242011
SIC: 2834 Pharmaceutical Preparations